Search

Search bills, members, committees and pages...

H.R. 2075

U.S. HouseIn House Committee

Summary

H.R. 2075, the Protecting Life and Integrity in Research Act of 2025, was introduced in the House on Mar 11, 2025 by Rep. Robert Onder (R) with 33 co-sponsors. It was referred to Energy And Commerce, and last saw action on Mar 11, 2025: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 2075 has 33 co-sponsors.

hb2075/introduced-in-house.txt
119 HR 2075 IH: Protecting Life and Integrity in Research Act of 2025
U.S. House of Representatives
2025-03-11
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 2075 IN THE HOUSE OF REPRESENTATIVES March 11, 2025 Mr. Onder (for himself, Mr. Smith of New Jersey , Mr. Latta , Mr. Kelly of Mississippi , Mrs. Miller of Illinois , Mr. Harris of Maryland , Mr. Green of Tennessee , Mr. LaMalfa , Mr. Grothman , Mr. Cloud , Mr. Self , Mr. Weber of Texas , Mr. Stauber , Mr. Ellzey , Mr. Ezell , Mr. Guest , Mr. Burchett , Mr. Crane , Mr. Fallon , Mrs. Biggs of South Carolina , Mr. Palmer , Mr. Biggs of Arizona , Ms. Greene of Georgia , and Mr. Fleischmann ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.
1.
Short title
This Act may be cited as the Protecting Life and Integrity in Research Act of 2025 .
2.
No research involving human fetal tissue obtained pursuant to an induced abortion
(a)
In general
(1)
In general
No Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion.
(2)
Development of new, ethical cell lines
Subsection (a) does not limit the authority of any Federal department, agency, or office to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion.
(3)
Research involving human fetal tissue obtained after a miscarriage or stillbirth permitted
Any research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act ( 42 U.S.C. 289g–1 ).
(b)
Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirth
Section 498A of the Public Health Service Act ( 42 U.S.C. 289g–1 ) is amended—
(1)
in the section heading, by striking
transplantation of fetal tissue and inserting
human fetal tissue obtained after a miscarriage or stillbirth ;
(2)
by amending subsection (a) to read as follows:
(a)
Establishment of program
The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.
;
(3)
in subsection (b)—
(A)
in paragraph (1)(B), by inserting if the human fetal tissue is intended for transplantation, before the donation ; and
(B)
in paragraph (2)—
(i)
by striking subparagraph (A); and
(ii)
by redesignating subparagraphs (B) and (C) as (A) and (B), respectively;
(4)
in subsection (c)(1)(B), by striking pursuant to a spontaneous or induced abortion or pursuant to and inserting after a miscarriage or ; and
(5)
by amending subsection (g) to read as follows:
(g)
Definitions
In this section:
(1)
Human fetal tissue
The term human fetal tissue means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth.
(2)
Miscarriage
The term miscarriage means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.
(3)
Stillbirth
The term stillbirth means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.
(4)
Unborn child
The term unborn child has the meaning given such term in section 1841(d) of title 18, United States Code.
.
(c)
Conforming repeal
Section 113 of the National Institutes of Health Revitalization Act of 1993 ( 42 U.S.C. 289g–1 note) is repealed.
3.
Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion
(a)
In general
Section 498B(c)(1) of the Public Health Service Act ( 42 U.S.C. 289g–2(c)(1) ) is amended to read as follows:
(1)
solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—
(A)
a human pregnancy was deliberately initiated to provide such tissue; or
(B)
the tissue was obtained pursuant to an induced abortion; or
.
(b)
Conforming changes
Section 498B of the Public Health Service Act ( 42 U.S.C. 289g–2 ), as amended by subsection (a), is further amended—
(1)
by striking subsection (b);
(2)
by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and
(3)
in subsection (c), as redesignated—
(A)
in paragraph (1), by striking (a), (b), or (c) and inserting (a) or (b) ; and
(B)
in paragraph (2), by striking or (b)(3) .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-03-11
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.

Sponsors

Rep. Robert Onder (R) sponsors H.R. 2075, and 33 members have co-sponsored it, 23 of them from the day it was introduced.

Committees

H.R. 2075 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Mar 11, 2025 · 1,636 Bills

Actions

H.R. 2075 has taken 2 actions since Mar 11, 2025.

ChamberAction
Mar 11, 2025
House
Introduced in House
Mar 11, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 2075 has not gone to a roll call.

1 bill is related to H.R. 2075.

Titles

H.R. 2075 goes by 3 titles, 1 of them short titles.

  • Protecting Life and Integrity in Research Act of 2025 — Display Title
  • Protecting Life and Integrity in Research Act of 2025 — Short Title(s) as Introduced
  • To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue. — Official Title as Introduced

Lobbying

1 client hired 1 firm and 8 registered lobbyists who named H.R. 2075 in 3 quarterly filings, 2025. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Budget/Appropriations, Civil Rights/Civil Liberties, Constitution, Defense, District of Columbia, Family issues/Abortion/Adoption, Foreign Relations, Government Issues.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
SUSAN B ANTHONY LISTVirginia13

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
SUSAN B ANTHONY LIST13

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
SUSAN B ANTHONY LISTSUSAN B ANTHONY LIST2025 first_quarter$600K1st Quarter - Report
SUSAN B ANTHONY LISTSUSAN B ANTHONY LIST2025 second_quarter$490K2nd Quarter - Report
SUSAN B ANTHONY LISTSUSAN B ANTHONY LIST2025 third_quarter$360K3rd Quarter - Report

Classification

The Congressional Research Service files H.R. 2075 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 2075’s is Health.

hr2075/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 2075, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 45 (Tuesday, March 11, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. ONDER:H.R. 2075.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H1152]

Source: congress.gov · legiscan.com